Disease/Infection News

RSS

Additional data from Sanofi's quadrivalent inactivated influenza vaccine study

Sanofi Pasteur, the vaccines division of Sanofi, announced today the results of a new study evaluating the immunogenicity and safety of an investigational quadrivalent inactivated influenza vaccine (QIV) among adults 65 years of age and older.

22 Oct 2011

HIV/AIDS clinic in Pakistan working to fight stigma, provide treatment

Inter Press Service reports on the Family Care Centre for people living with HIV/AIDS in Pakistan, which opened in Peshawar on September 1 "in the hope of breaking the stigma surrounding HIV/AIDS" in a region where myths surrounding the disease and its transmission are prevalent.

22 Oct 2011

Much work remains to be done in fight against malaria

Positive results announced this week from a large clinical trial testing the efficacy of the RTS,S malaria vaccine are "encouraging," but they are also "a reminder of how much work remains to be done," an Economist editorial reports.

22 Oct 2011

Committed action, continued funding needed in global campaign against TB

A Lancet editorial responds to WHO's sixteenth annual report on global tuberculosis (TB) control, released on Oct 11, which shows that the incidence of tuberculosis has been falling worldwide since 2002, writing, "Successes in disease control in China and other countries show what sustained political and economic support can achieve. Rather than waiting for the elixir of economic success to arrive in all high-burden countries, committed action by donors, agencies, and governments in the most challenging settings is needed in the global campaign against tuberculosis."

22 Oct 2011

JAMA examines KFF/UNAIDS analysis on global HIV/AIDS funding

A news and perspectives piece in the current issue of JAMA examines a recent funding analysis from the Kaiser Family Foundation and UNAIDS showing that "governments that support treatment and services for people with HIV/AIDS in low- and middle-income countries cut their annual contributions in 2010 by 10 percent," spending $6.9 billion last year compared with $7.6 billion in 2009.

22 Oct 2011

Romark announces results from NT-300 Phase 2B-3 trial on influenza

Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.

22 Oct 2011

E-voucher program providing food to malnourished Zimbabweans living with HIV, TB

An electronic voucher system, introduced by the World Food Programme (WFP) and implemented by the health ministry and non-governmental organizations, is helping Zimbabweans living with HIV/AIDS and tuberculosis (TB) and their families obtain food and fight malnutrition, PlusNews reports.

22 Oct 2011

PATH B programme for patients with hepatitis B launches in Europe

A pioneering educational resource, designed to improve the lives of people living with chronic hepatitis B, was launched today at an annual conference organised by Bristol-Myers Squibb in Hong Kong where 26 patient advocacy groups from 14 countries and regions gathered to discuss viral hepatitis.

22 Oct 2011

Water shortages lead to cholera threat in Harare, government says measures in place to contain outbreak

Radio VOP reports on water shortages in the high-density suburbs of the Zimbabwean capital of Harare, writing that some "have gone for a week without water raising fears of a cholera outbreak and bringing back fresh memories of the 4,000 people across the country killed in a cholera disaster in 2008."

22 Oct 2011

Common risk factors for hepatocellular cancer

Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to a cohort study published online October 21 in the Journal of the National Cancer Institute.

22 Oct 2011

Boehringer Ingelheim announces new data from hepatitis C virus portfolio

Boehringer Ingelheim announced today that new data from its hepatitis C virus (HCV) portfolio will be presented in scientific sessions at The Liver Meeting 2011, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 4 - November 8 in San Francisco, CA.

22 Oct 2011

Human innovation will lead to malaria eradication

Noting advances in bednet, mosquito repellent and malaria vaccine technologies, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, writes in a post on the foundation's "Impatient Optimists" blog, "People used to say eradication was impossible, but we remain optimistic because human beings have a spectacular ability to innovate."

21 Oct 2011

Wolbachia study reveals novel approaches to control insects transmitting deadly diseases

Researchers at Boston University have made discoveries that provide the foundation towards novel approaches to control insects that transmit deadly diseases such as dengue fever and malaria through their study of the Wolbachia bacteria.

21 Oct 2011

American robin plays a key role in transmission of West Nile virus

After its initial appearance in New York in 1999, West Nile virus spread across the United States in just a few years and is now well established throughout North and South America.

21 Oct 2011

Antimicrobial copper surfaces reduce hospital acquired infections in ICU rooms

Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent and resulted in a 41 percent reduction in the hospital acquired infection rate.

21 Oct 2011

Nasal irrigation safe and effective for people with chronic sinus

Before reaching for an over-the-counter medication to relieve cold and allergy symptoms, try a simple source of relief that's been around for centuries.

21 Oct 2011

India must stay the course in efforts to eradicate polio

"Clearly, there is no room for complacency" in India's efforts to eradicate polio, defined by the WHO as no recorded case of the disease for three years, because "the goal of complete eradication is within reach," Deepak Gupta, a senior U.N. professional in Strategic Health/Development Communication, writes in an Asia Sentinel opinion piece.

21 Oct 2011

The Guardian interviews GlaxoSmithKline lead researcher about new malaria vaccine

The Guardian features an interview with Moncef Slaoui, now chair of research and development at GlaxoSmithKline, who discusses his 23-year involvement in the research leading to the RTS,S malaria vaccine that has shown to halve the risk of malaria among African children.

21 Oct 2011

Aid groups, health ministry plan to administer oral cholera vaccine to 100,000 Haitians

Working in conjunction with the Haitian Ministry of Health and the Haitian aid group GHESKIO, Boston-based Partners In Health (PIH) will begin an immunization campaign in January aimed at providing two doses of the oral cholera vaccine Shanchol "to 100,000 Haitians living in two vulnerable communities: a neighborhood in Port-au-Prince, where potable water and latrines are luxuries, and to an isolated rural village in the lower Artibonite Valley region," the Miami Herald reports.

21 Oct 2011

Bringing NTDs to the forefront of the global health agenda

In this "End the Neglect" blog post, Neeraj Mistry, managing director of the Global Network for Neglected Tropical Diseases, reports on the global burden of neglected tropical diseases (NTDs) in anticipation of the World Health Summit set to take place from October 23 to 26 in Berlin, Germany.

21 Oct 2011